In additional analyses, we did not observe transcriptional downregulation of FANCA, FANCC, FANCD1, FANCD2, FANCE or FANCG mRNA and found no evidence of methylation in the CpG islands of any of these genes in our ovarian cancer cell line panel. The gene discussed is BRCA2; the disease is ovarian carcinoma.